C4 Therapeutics, Inc. (CCCC) vs Embecta Corp. (EMBC)
A side-by-side comparison of C4 Therapeutics, Inc. and Embecta Corp. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CCCC
C4 Therapeutics, Inc.
$2.86HealthcareDelayed quote: Oct 6, 2026, 12:55 PM EDT
EMBC
Embecta Corp.
$6.09HealthcareDelayed quote: Oct 6, 2026, 12:50 PM EDT
Total return — CCCC vs EMBC
growth of $100 · dividends reinvested · last 5yCCCC -87.1% (-33.6%/yr)EMBC -85.5% (-32.1%/yr)EMBC compounded faster over this window
CCCC EMBC
CCCC vs EMBC: by the numbers
- •EMBC is the larger company ($361M vs $316M market cap).
- •EMBC is profitable (8.59% net margin) while CCCC runs a net loss (-289.44%).
- •CCCC grew revenue faster over the past five years (0.65% vs -0.09% CAGR).
- •EMBC pays a dividend (5.44% yield), while CCCC has no payments in the available dividend history.
Metrics side by side
Valuation
| Metric | CCCC | EMBC |
|---|---|---|
| P/E ratio | N/A | 4.11 |
| Forward P/E | N/A | 3.45 |
| P/S ratio | 9.02 | 0.35 |
| P/B ratio | 1.28 | N/A |
| EV / EBITDA | N/A | 5.40 |
| FCF yield | N/A | 45.59% |
Profitability
| Metric | CCCC | EMBC |
|---|---|---|
| Gross margin | 77.81% | 59.89% |
| Operating margin | -290.68% | 24.85% |
| Net margin | -289.44% | 8.59% |
| ROE | -41.02% | N/A |
| ROIC | -35.92% | 17.99% |
Dividends
| Metric | CCCC | EMBC |
|---|---|---|
| Dividend yield | N/A | 5.44% |
| Payout ratio | N/A | 21.62% |
Growth (annualized)
| Metric | CCCC | EMBC |
|---|---|---|
| Revenue CAGR (5Y) | 0.65% | -0.09% |
| EPS CAGR (5Y) | N/A | -26.22% |
| FCF CAGR (5Y) | N/A | -16.77% |
| Total return CAGR (5Y) | -41.77% | N/A |
Frequently asked
- Which has grown faster, CCCC or EMBC?
- Over the past five years, CCCC grew revenue faster — CCCC at a 0.65% CAGR versus EMBC at -0.09%.
- Does CCCC or EMBC pay a bigger dividend?
- EMBC pays a dividend (5.44% yield), while CCCC has no payments in the available dividend history.
- Is CCCC or EMBC more profitable?
- EMBC runs the higher net margin — CCCC at -289.44% versus EMBC at 8.59%.
Go deeper
Dig into the metrics
Embecta P/E ratioEmbecta dividend yieldC4 Therapeutics ROEEmbecta ROEC4 Therapeutics operating marginEmbecta operating marginC4 Therapeutics revenue growthEmbecta revenue growthC4 Therapeutics free cash flowEmbecta free cash flow
C4 Therapeutics & Embecta appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.